Rosen Law Firm’s probe into Tandem Diabetes Care (TNDM) after a voluntary correction of certain t:slim X2 insulin pumps, and the roughly 20% share drop that followed, has investors reassessing risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback